General Information
Novo Nordisk NN9541-4945
Investigation of the safety and efficacy of once-weekly NNC0519-0130 in participants with type 2 diabetes – a dose-finding study
| Protocol | NN9541-4945 |
|---|---|
| Identifier | |
| UID | e79b1283-f480-4b2e-bb52-75a482e9e567 |
| Status | Follow-up |
| Phase | 2 |
| Category | Diabetes Type 2 / Adult |
| Launch Year | 2024 |
| NCT Number | - |
| Created | 2023-09-25 17:04 |
| Last Updated | 2025-01-07 15:30 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2024-11-11 | No |
| Enrollment Open | 2024-04-08 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2024-03-06 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohseni, Rizwana | RMohseni | No |
| Recruiter | Gomez, Kathie | KGomez | No |
| Coordinator | Valenzuela, Louisito | LValenzuela | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Novo Nordisk |
|---|---|
| Division | Novo Nordisk |
| Team | Novo Nordisk |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | IQVIA Clinical Trial Payments |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | PaleGoldenrod |
| Currency | - |
